The ORC Patient/Tumor Classification--New Approach: A New Challenge with Special Consideration for the Lung (Operability (O), RESECTABILITY (R) and Curability) (Clinical Report) The ORC Patient/Tumor Classification--New Approach: A New Challenge with Special Consideration for the Lung (Operability (O), RESECTABILITY (R) and Curability) (Clinical Report)

The ORC Patient/Tumor Classification--New Approach: A New Challenge with Special Consideration for the Lung (Operability (O), RESECTABILITY (R) and Curability) (Clinical Report‪)‬

Journal of Cancer Therapy 2011, June, 2, 2

    • $5.99
    • $5.99

Publisher Description

1. Introduction Each year a large number of patients are seen with thoracic tumors. Most of these patients are afflicted with tumors of the lung and in particular with carcinoma of the lung. The patients are seen by their primary and consulting physicians and are classified according to their tumor in many instances. The current most frequently used tumor classification is the TNM classification. This classification is based on the tumor size, the nodal assessment and the metastatic condition of the patient. However, the TNM classification process does not take the patient's physical condition into consideration-only the tumor considerations. Therefore, prognosis and statistics may be skewed as a result of the condition of the patient even when they theoretically may have potentially curable lesions. For a number of years, we have reviewed and considered the patients from another non TNM standpoint utilizing a process or classification entitled the ORC classification. This classification takes the patient's physical condition into consideration when reviewing treatment options. In addition, the TNM program may be utilized as a portion of this patient/tumor evaluation. More recently, a number of articles have been published suggesting that there are potential problems related to TNM staging and suggesting modification of the system [1,2].

GENRE
Health, Mind & Body
RELEASED
2011
June 1
LANGUAGE
EN
English
LENGTH
10
Pages
PUBLISHER
Scientific Research Publishing, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
238.8
KB

More Books Like This

Foundations of Colorectal Cancer (Enhanced Edition) Foundations of Colorectal Cancer (Enhanced Edition)
2021
Cancer Cancer
2019
Practice Guidelines for Tumor Marker Use in the Clinic. Practice Guidelines for Tumor Marker Use in the Clinic.
2002
The Lymphatic System in Colorectal Cancer (Enhanced Edition) The Lymphatic System in Colorectal Cancer (Enhanced Edition)
2022
Prompt, Accurate Diagnosis of Pediatric Cancer and Leukemia for Pediatricians, Orthopedists, and Family Practitioners Prompt, Accurate Diagnosis of Pediatric Cancer and Leukemia for Pediatricians, Orthopedists, and Family Practitioners
2011
Digestive System Malignancies (Enhanced Edition) Digestive System Malignancies (Enhanced Edition)
2022

More Books by Journal of Cancer Therapy

Adjuvant Treatment for High-Risk Operable Prostate Cancer (Report) Adjuvant Treatment for High-Risk Operable Prostate Cancer (Report)
2010
Antioxidant Potential Some Medicinal Plants of Central India (Report) Antioxidant Potential Some Medicinal Plants of Central India (Report)
2010
Cytostatic Activity of Some Novel Amidocarbamate Derivatives of Ketoprofen (Clinical Report) Cytostatic Activity of Some Novel Amidocarbamate Derivatives of Ketoprofen (Clinical Report)
2010
Genetic Polymorphisms of Hepatic Abc-Transporter in Patients with Hepatocellular Carcinoma (Report) Genetic Polymorphisms of Hepatic Abc-Transporter in Patients with Hepatocellular Carcinoma (Report)
2010
Early Diagnosis of Cardiac Toxicity Related to Antineoplastic Treatment (Clinical Report) Early Diagnosis of Cardiac Toxicity Related to Antineoplastic Treatment (Clinical Report)
2011
Digital Ischemia in Patients with Solid Tumors: A Case Report and Review of the Literature (Case Study) Digital Ischemia in Patients with Solid Tumors: A Case Report and Review of the Literature (Case Study)
2011